Drug Shortage Report for TEVA-MOMETASONE
| Report ID | 250393 |
| Drug Identification Number | 02475863 |
| Brand name | TEVA-MOMETASONE |
| Common or Proper name | MOMETASONE FURO SPRAY 50MCG |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MOMETASONE FUROATE |
| Strength(s) | 50MCG |
| Dosage form(s) | SPRAY, METERED DOSE |
| Route of administration | NASAL NASAL |
| Packaging size | 18G |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-02-12 |
| Estimated end date | 2026-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-13 |
| Company comments | Under allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v22 | 2025-11-13 | French | Compare |
| v21 | 2025-11-13 | English | Compare |
| v20 | 2025-09-25 | French | Compare |
| v19 | 2025-09-25 | English | Compare |
| v18 | 2025-06-27 | French | Compare |
| v17 | 2025-06-27 | English | Compare |
| v16 | 2025-06-13 | French | Compare |
| v15 | 2025-06-13 | English | Compare |
| v14 | 2025-06-05 | French | Compare |
| v13 | 2025-06-05 | English | Compare |
| v12 | 2025-05-22 | French | Compare |
| v11 | 2025-05-22 | English | Compare |
| v10 | 2025-04-24 | French | Compare |
| v9 | 2025-04-24 | English | Compare |
| v8 | 2025-02-28 | French | Compare |
| v7 | 2025-02-28 | English | Compare |
| v6 | 2025-02-28 | French | Compare |
| v5 | 2025-02-28 | English | Compare |
| v4 | 2025-02-20 | French | Compare |
| v3 | 2025-02-20 | English | Compare |